With more than 1,880,000 infections, the country already far exceeds the highest mark in 2015. The government declared a state of emergency.
Brazil beat this Monday the historical record of dengue caseswith more than 1.88 million infections in just over two and a half months compared to 1.68 for all of 2015, the year that had the maximum number of records to date.
The country already exceeds the total reported in the previous record year by 200,000 casesaccording to data released by the Ministry of Health, which represents a new milestone for a disease on the rise due to climate change.
Dengue: Brazil’s new record
In the first decade of the 2000s, Brazil recorded an average of just over 400,000 cases per year, but in the period from 2011 to 2023 this figure rose above one million. Last week, Brazil had already exceeded the total number of cases for 2023, when the effects of the virus began to be felt more. El Niño climate phenomenon and the high temperaturesfactors to which specialists attribute the increase in infections.
dengue 1200.jpg
Pixabay
The disease, which is transmitted by a mosquito and causes high fever, has caused 561 deaths, with another 1,020 under investigation.
State of emergency in Brazil due to Dengue cases
In this alert context, the city of Saint Paulthe largest in South America, decreed this Monday the state of emergency after having reached an incidence of 414 cases per 100,000 inhabitants.
He City hall announced last week that he would reinforce the teams in charge of making home visitss, as well as to extend healthcare hours.
The request of the Government of Brazil due to the increase in Dengue cases
While, The federal government estimates that 4.2 million cases can be reached by the end of 2024and asked the population take the necessary measures to prevent the spread of the disease, such as avoiding the accumulation of stagnant water in homes and gardens.
Brazil became in February in the first country in the world in offering the dengue vaccine through the public health system, although the low number of doses available has limited its application to only children and adolescents.
Source: Ambito
